Table 5.
Risk Model | Cutoff | Range | IQR | |
---|---|---|---|---|
Radiomics_DCE_MR | 1.118 | |||
Development | 0.298–1.118 | 0.755–0.789 | ||
Validation | 0.325–1.794 | 0.875–0.927 | ||
Radiomics_Perfusion | 1.043 | |||
Development | 0.594–1.337 | 0.908–0.922 | ||
Validation | 0.611–1.327 | 0.892–0.915 | ||
HRS-only | 1.067 | |||
Development | 0.322–1.691 | 0.823–1.255 | ||
Validation | 0.396–1.533 | 0.872–1.181 | ||
Clinical | 0.318 | |||
Development | 0.170–1.816 | 0.170–0.654 | ||
Validation | 0.170–2.216 | 0.318–0.723 | ||
Combined habitat | 1.867 | |||
Development | 0.337–16.442 | 0.981–4.327 | ||
Validation | 0.321–22.717 | 1.132–5.186 |